Transient osteoporosis of the hip (TOH) in pregnancy is characterized by severe pain in unilateral or bilateral hips and has been diagnosed as localized osteopenia. However, we evaluated a case of unilateral TOH with generalized profound osteoporosis involving both the hips and the lumbar vertebrae by dual-energy X-ray absorptiometry. The diagnosis was based on the clinical course and confirmed by magnetic resonance imaging. Three-dimensional helical computed tomography (3D-CT), which has not been used in patients with TOH, revealed a markedly thin bilateral proximal femoral cortex, particularly in the symptomatic femoral head. Despite the difference in the severity of bone destruction between the two femora, they both showed the same pattern of damage on 3D-CT. Furthermore, despite continuing treatment with the same dose of alendronate and calcitriol, a high rate of bone mineral density gain, involving both the femora and lumbar vertebrae, was limited to the early postpartum months. A majority of reported female patients with TOH are pregnant. Thus, the association between TOH and pregnancy was not considered to be fortuitous, and chemical or hormonal factors related to pregnancy may play an etiologic role in this disease. The possible etiologies of TOH in pregnancy are also discussed.

Keywords:
Magnetic resonance imaging, Pregnancy, Three-dimensional helical computed tomography, Transient hip osteoporosis, Urinary cross-linked type I collagen N-telopeptide
1.
Curtiss PH Jr, Kincaid WE: Transitory demineralization of the hip in pregnancy: a case report of three cases. J Bone Joint Surg Am 1959;41:1327-1333.
2.
Shifrin LZ, Reis ND, Zinman H, Besser MI: Idiopathic transient osteoporosis of the hip. J Bone Joint Surg Br 1987;69:769-773.
3.
Axt-Fliedner R, Schneider G, Seil R, Friedrich M, Mink D, Schmidt W: Transient bilateral osteoporosis of the hip in pregnancy. A case report and review of the literature. Gynecol Obstet Invest 2001;51:138-140.
4.
Funk JL, Shoback DM, Genant HK: Transient osteoporosis of the hip in pregnancy: natural history of changes in bone mineral density. Clin Endocrinol (Oxf) 1995;43:373-382.
5.
Hagio H, Okano T, Teshima R, Nishi T, Yamamoto K: Insufficiency fracture of the femoral head in patients with severe osteoporosis - report of 2 cases. Acta Orthop Scand 1999;70:87-89.
6.
Miyanishi K, Yamamoto T, Nakashima Y, Shuto T, Jingushi S, Noguchi Y, Iwamoto Y: Subchondral changes in transient osteoporosis of the hip. Skeletal Radiol 2001;30:255-261.
7.
Yamaga A, Taga M, Minaguchi H: Changes in urinary excretions of C-telopeptide and cross-linked N-telopeptide of type I collagen during pregnancy and puerperium. Endocr J 1997;44:733-738.
8.
Black AJ, Topping J, Durham B, Farquharson RG, Fraser WD: A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy. J Bone Miner Res 2000;15:557-563.
9.
Anai T, Tomiyasu T, Arima K, Miyakawa I: Pregnancy-associated osteoporosis with elevated levels of circulating parathyroid hormone-related protein: a report of two cases. J Obstet Gynecol Res 1999;25:63-67.
10.
Noorda RJ, van der Aa JP, Wuisman PI, David EF, Lips PT, van der Valk P: Transient osteoporosis and osteogenesis imperfecta: a case report. Clin Orthop 1997;337:249-255.
11.
Iwahashi M, Muragaki Y, Ooshima A, Umesaki N: Decreased type I collagen expression in human uterine cervix during pregnancy. J Clin Endocrinol Metab 2003;88:2231-2235.
12.
Uldbjerg N, Ekman G, Malmström A, Olsson K, Ulmsten U: Ripening of the human uterine cervix related to changes in collagen, glycosaminoglycans, and collagenolytic activity. Am J Obstet Gynecol 1983;147:662-666.
13.
Osmers R, Rath W, Adelmann-Grill BC, Fittkow C, Kuloczik M, Szeverényi M, Tschesche H, Kuhn W: Origin of cervical collagenase during parturition. Am J Obstet Gynecol 1992;166:1455-1460.
14.
Brenner RE, Vetter U, Bollen AM, Mörike M, Eyre DR: Bone resorption assessed by immunoassay of urinary cross-linked collagen peptides in patients with osteogenesis imperfecta. J Bone Miner Res 1994;9:993-997.
15.
Weitzel SH, Percy AJ: Transient osteoporosis of the hip associated with pregnancy and osteogenesis imperfecta. Orthopedics 2000;23:1291-1292.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.